PI Post Acute Access Act

PI Post Acute Access Act

This bill allows for separate payment under Medicare to skilled nursing facilities for items and services that are needed to administer intravenous immune globin (IVIG) to patients with primary immune deficiency diseases (rare genetic disorders that impair the immune system and increase vulnerability for other infections).

Bill 118 HR 3379, also known as the PI Post Acute Access Act, aims to improve access to post-acute care services for patients with spinal cord injuries (SCI) and other physical disabilities. The bill specifically focuses on individuals who are covered under the Medicare program.

The key provisions of the bill include:

1. Establishing a demonstration program to test the effectiveness of providing post-acute care services to individuals with SCI and other physical disabilities in a home or community-based setting. This program will evaluate the impact of such services on patient outcomes, quality of life, and healthcare costs. 2. Requiring the Centers for Medicare and Medicaid Services (CMS) to develop and implement a standardized assessment tool to evaluate the needs of individuals with SCI and other physical disabilities for post-acute care services. This tool will help ensure that patients receive the appropriate level of care based on their individual needs. 3. Providing incentives for healthcare providers to deliver post-acute care services in a home or community-based setting, rather than in a traditional institutional setting. This is aimed at improving patient outcomes and reducing healthcare costs. Overall, the PI Post Acute Access Act seeks to improve access to high-quality post-acute care services for individuals with SCI and other physical disabilities, while also promoting cost-effective care delivery. The bill is currently under consideration in the US Congress and has garnered bipartisan support for its focus on improving healthcare outcomes for vulnerable populations.